StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
XENE

Xenon Pharmaceuticals Inc.

XENE Nasdaq Pharmaceutical Preparations EDGAR ↗
$62.26
-1.93 -3.01%

Key statistics

from XBRL data in SEC filings
Market cap
$6.02B
Revenue (TTM)
$0.00
Net income (TTM)
-$383M
EPS (TTM)
$-4.70
P/E ratio
Dividend yield
Free cash flow
-$280M
Cash
$546M
Total assets
$1.39B
Gross margin
52-week range
$30.65 – $72.66

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change; Shareholder vote results Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2026 8-K Director or officer change Apr 13, 2026 8-K Other events Mar 13, 2026 8-K Entered a material agreement; Other events Mar 12, 2026 8-K Regulation FD disclosure Mar 9, 2026 8-K Other events Feb 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2026 8-K Director or officer change Dec 1, 2025 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 3, 2025 8-K/A Director or officer change; Other events Oct 17, 2025 8-K Director or officer change Oct 16, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 11, 2025 8-K Director or officer change Jul 3, 2025 8-K Shareholder vote results Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 12, 2025 8-K Other events Mar 17, 2025 8-K Changed accountants Mar 5, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Feb 27, 2025 8-K Director or officer change Jan 17, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 8-K Shareholder vote results Jun 5, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 9, 2024 8-K Director or officer change Apr 19, 2024 8-K Other events Mar 8, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 29, 2024 8-K Entered a material agreement; Other events Nov 30, 2023 8-K Other events Nov 27, 2023 8-K Other events Nov 9, 2023